Phenothiazine Analogues

CAS No. 423749-25-1

Phenothiazine Analogues( —— )

Catalog No. M37554 CAS No. 423749-25-1

3-Amino-1-(2-chloro-10H-phenothiazin-10-yl)-1-propanone is involved in the synthesis of phenothiazine series compounds.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 627 In Stock
10MG 941 In Stock
25MG 1596 In Stock
50MG 2345 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Phenothiazine Analogues
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Amino-1-(2-chloro-10H-phenothiazin-10-yl)-1-propanone is involved in the synthesis of phenothiazine series compounds.
  • Description
    3-Amino-1-(2-chloro-10H-phenothiazin-10-yl)-1-propanone is involved in the synthesis of phenothiazine series compounds.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    423749-25-1
  • Formula Weight
    304.8
  • Molecular Formula
    C15H13ClN2OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(N1C=2C=CC=CC2SC3=CC=C(Cl)C=C31)CCN
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (Ile5,Trp23,Tyr36)-p...

    (Ile5,Trp23,Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.

  • BCI-215

    BCI-215 causes selective cancer cell cytotoxicity in part through non-redox-mediated activation of MAPK signaling.

  • BRD7716

    BRD7116 competitively binds to bacterial DNA gyrase, with cell-non-autonomous anti-leukemia activity.